Breast cancer stem cells: A new challenge for breast cancer treatment

Frontiers in Bioscience

Volumn 16, Issue 5, 2011, Pages 1824-1832

  Jain, Prachi ^a   Alahari, Suresh K ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer stem cells; Epithelial mesencymal transition; Fak; Hedgehog; Her2; Mammary stem cells; Notch; Progenitor cells; PTEN micro RNA; Review; Self renewal; Tumorigenic; Wnt

Indexed keywords

ERINACEIDAE;

FOCAL ADHESION KINASE; MICRORNA; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR TWIST; WNT PROTEIN;

ANIMAL; BREAST; BREAST TUMOR; CANCER STEM CELL; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETICS; HUMAN; METASTASIS; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTO ONCOGENE; REVIEW;

ANIMALS; BREAST; BREAST NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENES, ERBB-2; HEDGEHOG PROTEINS; HUMANS; MICE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PTEN PHOSPHOHYDROLASE; RECEPTORS, NOTCH; TWIST TRANSCRIPTION FACTOR; WNT PROTEINS;

EID: 79955030842     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3824     Document Type: Article

References (55)

1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu and M. J. Thun: Cancer statistics, 2007. CA Cancer J Clin, 57(1), 43-66 (2007) (Pubitemid 46148091)
2. J. A. Martinez-Climent, E. J. Andreu and F. Prosper: Somatic stem cells and the origin of cancer. Clin Transl Oncol, 8(9), 647-63 (2006)
3. C. H. Park, D. E. Bergsagel and E. A. McCulloch: Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst, 46(2), 411-22 (1971)
4. W. R. Bruce and H. Van Der Gaag: A Quantitative Assay for the Number of Murine Lymphoma Cells Capable of Proliferation in vivo. Nature, 199, 79-80 (1963)
5. D. Bonnet and J. E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3(7), 730-7 (1997) (Pubitemid 27298715)
6. T. Reya, S. J. Morrison, M. F. Clarke and I. L. Weissman: Stem cells, cancer, and cancer stem cells. Nature, 414(6859), 105-11 (2001) (Pubitemid 33041634)
7. P. Dalerba, R. W. Cho and M. F. Clarke: Cancer stem cells: models and concepts. Annu Rev Med, 58, 267-84 (2007) (Pubitemid 46706514)
8. J. E. Visvader and G. J. Lindeman: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8(10), 755-68 (2008)
9. B. J. Huntly, H. Shigematsu, K. Deguchi, B. H. Lee, S. Mizuno, N. Duclos, R. Rowan, S. Amaral, D. Curley, I. R. Williams, K. Akashi and D. G. Gilliland: MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell, 6(6), 587-96 (2004) (Pubitemid 40017702)
10. E. C. Kordon and G. H. Smith: An entire functional mammary gland may comprise the progeny from a single cell. Development, 125(10), 1921-30 (1998) (Pubitemid 28274378)
11. M. Shackleton, F. Vaillant, K. J. Simpson, J. Stingl, G. K. Smyth, M. L. Asselin-Labat, L. Wu, G. J. Lindeman and J. E. Visvader: Generation of a functional mammary gland from a single stem cell. Nature, 439(7072), 84-8 (2006) (Pubitemid 43053633)
12. J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant, D. Choi, H. I. Li and C. J. Eaves: Purification and unique properties of mammary epithelial stem cells. Nature, 439(7079), 993-7 (2006) (Pubitemid 43292419)
13. C. Williams, L. Helguero, K. Edvardsson, L. A. Haldosen and J. A. Gustafsson: Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression. Breast Cancer Res, 11(3), R26 (2009)
14. F. A. Spring, R. Dalchau, G. L. Daniels, G. Mallinson, P. A. Judson, S. F. Parsons, J. W. Fabre and D. J. Anstee: The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene. Immunology, 64(1), 37-43 (1988)
15. G. Kristiansen, M. Sammar and P. Altevogt: Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol, 35(3), 255-62 (2004) (Pubitemid 40585311)
16. J. Friederichs, Y. Zeller, A. Hafezi-Moghadam, H. J. Grone, K. Ley and P. Altevogt: The CD24/P-selectinbinding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res, 60(23), 6714-22 (2000)
17. S. N. Thomas, F. Zhu, R. L. Schnaar, C. S. Alves and K. Konstantopoulos: Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem, 283(23), 15647-55 (2008)
18. B. Weigelt, J. L. Peterse and L. J. van 't Veer: Breast cancer metastasis: markers and models. Nat Rev Cancer, 5(8), 591-602 (2005) (Pubitemid 41081385)
19. T. S. Pandit, W. Kennette, L. Mackenzie, G. Zhang, W. Al-Katib, J. Andrews, S. A. Vantyghem, D. G. Ormond, A. L. Allan, D. I. Rodenhiser, A. F. Chambers and A. B. Tuck: Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment. Int J Oncol, 35(2), 297-308 (2009)
20. M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R. H. Datar and R. J. Cote: Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res, 12(19), 5615-21 (2006) (Pubitemid 44629587)
21. J. E. Draffin, S. McFarlane, A. Hill, P. G. Johnston and D. J. Waugh: CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res, 64(16), 5702-11 (2004) (Pubitemid 39095568)
22. E. Charafe-Jauffret, C. Ginestier, F. Iovino, J. Wicinski, N. Cervera, P. Finetti, M. H. Hur, M. E. Diebel, F. Monville, J. Dutcher, M. Brown, P. Viens, L. Xerri, F. Bertucci, G. Stassi, G. Dontu, D. Birnbaum and M. S. Wicha: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res, 69(4), 1302-13 (2009)
23. C. Ginestier, S. Liu, M. E. Diebel, H. Korkaya, M. Luo, M. Brown, J. Wicinski, O. Cabaud, E. Charafe-Jauffret, D. Birnbaum, J. L. Guan, G. Dontu and M. S. Wicha: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest, 120(2), 485-97
24. A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verastegui and A. Zlotnik: Involvement of chemokine receptors in breast cancer metastasis. Nature, 410(6824), 50-6 (2001) (Pubitemid 32225831)
25. M. Darash-Yahana, E. Pikarsky, R. Abramovitch, E. Zeira, B. Pal, R. Karplus, K. Beider, S. Avniel, S. Kasem, E. Galun and A. Peled: Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J, 18(11), 1240-2 (2004) (Pubitemid 39561563)
26. H. Schabath, S. Runz, S. Joumaa and P. Altevogt: CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci, 119(Pt 2), 314-25 (2006) (Pubitemid 43210700)
27. H. Hugo, M. L. Ackland, T. Blick, M. G. Lawrence, J. A. Clements, E. D. Williams and E. W. Thompson: Epithelial - mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol, 213(2), 374-83 (2007) (Pubitemid 47509716)
28. S. A. Mani, W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan, A. Y. Zhou, M. Brooks, F. Reinhard, C. C. Zhang, M. Shipitsin, L. L. Campbell, K. Polyak, C. Brisken, J. Yang and R. A. Weinberg: The epithelialmesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704-15 (2008) (Pubitemid 351636299)
29. A. P. Morel, M. Lievre, C. Thomas, G. Hinkal, S. Ansieau and A. Puisieux: Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3(8), e2888 (2008)
30. M. Santisteban, J. M. Reiman, M. K. Asiedu, M. D. Behrens, A. Nassar, K. R. Kalli, P. Haluska, J. N. Ingle, L. C. Hartmann, M. H. Manjili, D. C. Radisky, S. Ferrone and K. L. Knutson: Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res, 69(7), 2887-95 (2009)
31. S. K. Pal and M. Pegram: HER2 targeted therapy in breast cancer...beyond Herceptin. Rev Endocr Metab Disord, 8(3), 269-77 (2007) (Pubitemid 47524873)
32. H. Korkaya, A. Paulson, F. Iovino and M. S. Wicha: HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene, 27(47), 6120-30 (2008)
33. A. Magnifico, L. Albano, S. Campaner, D. Delia, F. Castiglioni, P. Gasparini, G. Sozzi, E. Fontanella, S. Menard and E. Tagliabue: Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin Cancer Res, 15(6), 2010-21 (2009)
34. T. Nakanishi, S. Chumsri, N. Khakpour, A. H. Brodie, B. Leyland-Jones, A. W. Hamburger, D. D. Ross and A. M. Burger: Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling. Br J Cancer, 102(5), 815-26
35. M. Luo and J. L. Guan: Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett, 289(2), 127-39
36. Y. J. Jan, B. S. Ko, C. Hsu, T. C. Chang, S. C. Chen, J. Wang and J. Y. Liou: Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma. Hum Pathol, 40(10), 1384-90 (2009)
37. M. Luo, H. Fan, T. Nagy, H. Wei, C. Wang, S. Liu, M. S. Wicha and J. L. Guan: Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res, 69(2), 466-74 (2009)
38. H. Harrison, G. Farnie, S. J. Howell, R. E. Rock, S. Stylianou, K. R. Brennan, N. J. Bundred and R. B. Clarke: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res, 70(2), 709-18
39. R. Rampal, A. S. Li, D. J. Moloney, S. A. Georgiou, K. B. Luther, A. Nita-Lazar and R. S. Haltiwanger: Lunatic fringe, manic fringe, and radical fringe recognize similar specificity determinants in O-fucosylated epidermal growth factor-like repeats. J Biol Chem, 280(51), 42454-63 (2005) (Pubitemid 43023218)
40. H. Hirose, H. Ishii, K. Mimori, D. Ohta, M. Ohkuma, H. Tsujii, T. Saito, M. Sekimoto, Y. Doki and M. Mori: Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors. Oncol Rep, 23(1), 35-43
41. J. Yang, S. A. Mani, J. L. Donaher, S. Ramaswamy, R. A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson and R. A. Weinberg: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117(7), 927-39 (2004) (Pubitemid 38798858)
42. F. Vesuna, A. Lisok, B. Kimble and V. Raman: Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia, 11(12), 1318-28 (2009)
43. B. Marty, V. Maire, E. Gravier, G. Rigaill, A. Vincent-Salomon, M. Kappler, I. Lebigot, F. Djelti, A. Tourdes, P. Gestraud, P. Hupe, E. Barillot, F. Cruzalegui, G. C. Tucker, M. H. Stern, J. P. Thiery, J. A. Hickman and T. Dubois: Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Res, 10(6), R101 (2008)
44. L. A. DeGraffenried, L. Fulcher, W. E. Friedrichs, V. Grunwald, R. B. Ray and M. Hidalgo: Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway. Ann Oncol, 15(10), 1510-6 (2004) (Pubitemid 39409742)
45. H. Korkaya, A. Paulson, E. Charafe-Jauffret, C. Ginestier, M. Brown, J. Dutcher, S. G. Clouthier and M. S. Wicha: Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol, 7(6), e1000121 (2009)
46. C. Lindvall, C. R. Zylstra, N. Evans, R. A. West, K. Dykema, K. A. Furge and B. O. Williams: The Wnt coreceptor Lrp6 is required for normal mouse mammary gland development. PLoS One, 4(6), e5813 (2009)
47. T. A. DiMeo, K. Anderson, P. Phadke, C. Fan, C. M. Perou, S. Naber and C. Kuperwasser: A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res, 69(13), 5364-73 (2009)
48. J. Taipale and P. A. Beachy: The Hedgehog and Wnt signalling pathways in cancer. Nature, 411(6835), 349-54 (2001) (Pubitemid 32467044)
49. S. Liu, G. Dontu, I. D. Mantle, S. Patel, N. S. Ahn, K. W. Jackson, P. Suri and M. S. Wicha: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res, 66(12), 6063-71 (2006)
50. R. Yi, M. N. Poy, M. Stoffel and E. Fuchs: A skin microRNA promotes differentiation by repressing 'stemness'. Nature, 452(7184), 225-9 (2008) (Pubitemid 351380241)
51. F. Yu, H. Yao, P. Zhu, X. Zhang, Q. Pan, C. Gong, Y. Huang, X. Hu, F. Su, J. Lieberman and E. Song: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131(6), 1109-23 (2007) (Pubitemid 350235025)
52. Y. Shimono, M. Zabala, R. W. Cho, N. Lobo, P. Dalerba, D. Qian, M. Diehn, H. Liu, S. P. Panula, E. Chiao, F. M. Dirbas, G. Somlo, R. A. Pera, K. Lao and M. F. Clarke: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 138(3), 592-603 (2009)
53. P. A. Gregory, A. G. Bert, E. L. Paterson, S. C. Barry, A. Tsykin, G. Farshid, M. A. Vadas, Y. Khew-Goodall and G. J. Goodall: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10(5), 593-601 (2008) (Pubitemid 351627379)
54. A. Sottoriva, P. M. Sloot, J. P. Medema and L. Vermeulen: Exploring cancer stem cell niche directed tumor growth. Cell Cycle, 9(8)
55. Q. Xu, X. Yuan, P. Tunici, G. Liu, X. Fan, M. Xu, J. Hu, J. Y. Hwang, D. L. Farkas, K. L. Black and J. S. Yu: Isolation of tumour stem-like cells from benign tumours. Br J Cancer, 101(2), 303-11 (2009)